Abnormal glucose measurements are common among intensive care unit (ICU) patients for numerous reasons and hypoglycemia is especially dangerous because these patients are often sedated and unable to relate the associated symptoms. Additionally, wide swings in blood glucose have been closely tied to increased mortality. Therefore, accurate and timely glucose measurement in this population is critical. Clinicians have several choices available to assess blood glucose values in the ICU, including central laboratory devices, blood gas analyzers, and point-of-care meters. In this review, the method of glucose measurement will be reviewed for each device, and the important characteristics, including accuracy, cost, speed of result, and sample volume, will be reviewed, specifically as these are used in the ICU environment. Following evaluation of the individual measurement devices and after considering the many features of each, recommendations are made for optimal ICU glucose determination.
PriscoLIscraFGanauMBerlotG.Early predictive factors on mortality in head injured patients: A retrospective analysis of 112 traumatic brain injured patients. J Neurosurg Sci.2012;56 (2): 131–6.
2.
ChiALissauerMEKirchoffnerJScaleaTMJohnsonSB, Effect of glycemic state on hospital mortality in critically ill surgical patients. Am Surg.2011;77 (11): 1483–9.
3.
MurphyC VCoffeyRCookCHGerlachATMillerSF, Early glycemic control in critically ill patients with burn injury. J Burn Care Res.2011;32 (6): 583–90.
4.
GianchandaniRYEsfandiariNHHaftJWPragerRLPop-BusuiR.Diabetes and stress hyperglycemia in the intensive care unit: Outcomes after cardiac surgery. Hosp Pract (Minneap).2012;40 (2): 22–30.
5.
RichardsJEKauffmannRMObremskeyWTMayAK, Stress-induced hyperglycemia as a risk factor for surgical-site infection in non-diabetic orthopaedic trauma patients admitted to the intensive care unit. J Orthop Trauma.2013;27 (1): 16–21.
6.
TayekCJTayekJA, Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis. World J Diabetes.2012;3 (2): 29–34.
7.
LazzeriCValenteSChiostriMAttanàPPicarielloCGensiniGF, The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: From insulin resistance to hyperglycemia. Acta Diabetol.2011. Epub ahead of print.
8.
American Diabetes Association. Standards of medical care in diabetes–2008. Diabetes Care.2008;31Suppl 1: S12–54.
9.
RodbardHWBlondeLBraithwaiteSSBrettEMCobinRHHandelsmanYHellmanRJellingerPSJovanovicLGLevyPMechanickJIZangenehF; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract.2007;13Suppl 1: 1–68.
10.
Van den BergheGWilmerAHermansGMeerssemanWWoutersPJMilantsIVan WijngaerdenEBobbaersHBouillonR.Intensive insulin therapy in the medical ICU. N Engl J Med.2006;354 (5): 449–61.
11.
Van den BergheGWoutersPWeekersFVerwaestCBruyninckxFSchetzMVlasselaersDFerdinandePLauwersPBouillonR.Intensive insulin therapy in critically ill patients. N Engl J Med.2001;345 (19): 1359–67.
12.
NICE-SUGAR Study Investigators, FinferSChittockDRSuSYBlairDFosterDDhingraVBellomoRCookDDodekPHendersonWRHébertPCHeritierSHeylandDKMcArthurCMcDonaldEMitchellIMyburghJANortonRPotterJRobinsonBGRoncoJJ, Intensive versus conventional glucose control in critically ill patients. N Engl J Med.2009;360 (13): 1283–97.
13.
MoweryNTGunterOLKauffmannRMDiazJJJrCollierBCMayAK, Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population. World J Surg.2012;36 (2): 270–7.
14.
D'AnconaGBertuzziFSacchiLPironeFStringiVArcadipaneABellazziRPilatoM.Iatrogenic hypoglycemia secondary to tight glucose control is an independent determinant for mortality and cardiac morbidity. Eur J Cardiothorac Surg.2011;40 (2): 360–6.
15.
GriesdaleDEde SouzaRJvan DamRMHeylandDKCookDJMalhotraADhaliwalRHendersonWRChittockDRFinferSTalmorD.Intensive insulin therapy and mortality among critically ill patients: A meta-analysis including NICE-SUGAR study data. CMAJ.2009;180 (8): 821–7.
16.
De JongheBAppere-De-VechiCFournierMTranBMerrerJMelchiorJCOutinH.A prospective survey of nutritional support practices in intensive care unit patients: What is prescribed? What is delivered?Crit Care Med.2001;29 (1): 8–12.
17.
PitkinADRiceMJ, Challenges to glycemic measurement in the perioperative and critically ill patient: A review. J Diabetes Sci Technol.2009;3 (6): 1270–81.
18.
BlandJMAltmanDG, Applying the right statistics: Analyses of measurement studies. Ultrasound Obstet Gynecol.2003;22 (1): 85–93.
19.
StorkADKempermanHErkelensDWVenemanTF, Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. Eur J Endocrinol.2005;153 (2): 275–81.
20.
BlandJMAltmanDG, Statistical methods for assessing agreement between two methods of clinical measurement. Lancet.1986;1 (8476): 307–10.
21.
AtkinSHDasmahapatraAJakerMAChorostMIReddyS.Fingerstick glucose determination in shock. Ann Intern Med.1991;114 (12): 1020–4.
22.
TangZDuXLouieRFKostGJ, Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med.2000;124 (4): 577–82.
23.
TangZLeeJHLouieRFKostGJ, Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med.2000;124 (8): 1135–40.
24.
JanssenWHarffGCaersMSchellekensA.Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem.1998;44 (11): 2379–80.
25.
TangZLouieRFLeeJHLeeDMMillerEEKostGJ, Oxygen effects on glucose meter measurements with glucose dehydrogenase- and oxidase-based test strips for point-of-care testing. Crit Care Med.2001;29 (5): 1062–70.
26.
WongXWSingh-LevettIHollingsworthLJShawGMHannCELotzTLinJWongOSChaseJG, A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther.2006;8 (2): 174–90.
27.
KovatchevBPClarkeWLBretonMBraymanKMcCallA.Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: Mathematical methods and clinical application. Diabetes Technol Ther.2005;7 (6): 849–62.
28.
KilgoreMLSteindelSJSmithJA, Evaluating stat testing options in an academic health center: Therapeutic turnaround time and staff satisfaction. Clin Chem.1998;44 (8 Pt 1): 1597–603.
29.
HowanitzPJJonesBA; College of American Pathologists. Comparative analytical costs of central laboratory glucose and bedside glucose testing: A College of American Pathologists Q-Probes study. Arch Pathol Lab Med.2004;128 (7): 739–45.
30.
RinkerG.Cost accounting applied to the clinical laboratory. Clin Lab Sci.1995;8 (6): 339–42.
31.
FoulkeGEHarlowDJ, Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med.1989;17 (11): 1143–5.
32.
BurrinJMPriceCP, Measurement of blood glucose. Ann Clin Biochem.1985;22 (Pt 4): 327–42.
33.
SacksDBArnoldMBakrisGLBrunsDEHorvathARKirkmanMSLernmarkAMetzgerBENathanDM; National Academy of Clinical Biochemistry; Evidence-Based Laboratory Medicine Committee of the American Association for Clinical Chemistry. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care.2011;34 (6): e61–99.
34.
RicosCAlvarezVCavaFGarcia-LarioJVHernandezAJimenezCVMinchinelaJPerichCSimonM.Current databases on biological variation: Pros, cons and progress. Scand J Clin Lab Invest.1999;59 (7): 491–500.
35.
BaigASiddiquiIJabbarAAzamSISabirSAlamSGhaniF.Comparision between bed side testing of blood glucose by glucometer vs centralized testing in a tertiary care hospital. J Ayub Med Coll Abbottabad.2007;19 (3): 25–9.
36.
Personal communication with Neil S. Harris.
37.
Bénéteau-BurnatBBocqueMCLorinAMartinCVaubourdolleM.Evaluation of the blood gas analyzer Gem PREMIER 3000. Clin Chem Lab Med.2004;42 (1): 96–101.
GijzenKMoolenaarDLWeustenJJPluimHJDemirAY, Is there a suitable point-of-care glucose meter for tight glycemic control? Evaluation of one home-use and four hospital-use meters in an intensive care unit. Clin Chem Lab Med.2012;50 (11): 1985–92.
40.
KrouwerJSCembrowskiGS, A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol.2010;4 (1): 75–83.
TonyushkinaKNicholsJH, Glucose meters: A review of technical challenges to obtaining accurate results. J Diabetes Sci Technol.2009;3 (4): 971–80.
43.
RaoLVJakubiakFSidwellJSWinkelmanJWSnyderML, Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction. Clin Chim Acta.2005;356 (1–2): 178–83.
44.
WuPMoreyTEHarrisNSGravensteinNRiceMJ, Intravenous fluids cause systemic bias in a conductivity-based point-of-care hematocrit meter. Anesth Analg.2012;114 (2): 314–21.
45.
StahlMBrandslundIJørgensenLGPetersenP HyltoftBorch-JohnsenKde Fine OlivariusN. Can capillary whole blood glucose and venous plasma glucose measurements be used interchangeably in diagnosis of diabetes mellitus?Scand J Clin Lab Invest.2002;62 (2): 159–66.
46.
CarstensenBLindströmJSundvallJBorch-JohnsenKTuomilehtoJ; DPS Study Group. Measurement of blood glucose: Comparison between different types of specimens. Ann Clin Biochem.2008;45 (Pt 2): 140–8.
47.
GrekSGravensteinNMoreyTERiceMJ, A cost-effective screening method for preoperative hyperglycemia. Anesth Analg.2009;109 (5): 1622–4.
48.
WinkelmanJWWybengaDRTanasijevicMJ, The fiscal consequences of central vs distributed testing of glucose. Clin Chem.1994;40 (8): 1628–30.
49.
KhanAIVasquezYGrayJWiansFHJrKrollMH, The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med.2006;130 (10): 1527–32.
50.
KlonoffDC, Intensive insulin therapy in critically ill hospitalized patients: Making it safe and effective. J Diabetes Sci Technol.2011;5 (3): 755–67.
